Hudson Bay Capital Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Hold |
0
| – | – | – | 1334 |
|
|
2022
Q1 | – | Sell |
-4,667
| Closed | -$946K | – | 1238 |
|
|
2021
Q4 | $946K | Sell |
4,667
-1,500
| -24% | -$304K | 0.01% | 789 |
|
|
2021
Q3 | $1.66M | Sell |
6,167
-1,166
| -16% | -$314K | 0.02% | 651 |
|
|
2021
Q2 | $1.89M | Buy |
7,333
+2,333
| +47% | +$601K | 0.02% | 618 |
|
|
2021
Q1 | $1.5M | Sell |
5,000
-333
| -6% | -$99.9K | 0.02% | 608 |
|
|
2020
Q4 | $1.36M | Sell |
5,333
-3,000
| -36% | -$765K | 0.01% | 417 |
|
|
2020
Q3 | $2.07M | Buy |
8,333
+445
| +6% | +$111K | 0.03% | 333 |
|
|
2020
Q2 | $2.74M | Sell |
7,888
-779
| -9% | -$271K | 0.05% | 264 |
|
|
2020
Q1 | $2.32M | Hold |
8,667
| – | – | 0.06% | 244 |
|
|
2019
Q4 | $2.81M | Buy |
8,667
+5,334
| +160% | +$1.73M | 0.06% | 226 |
|
|
2019
Q3 | $911K | Sell |
3,333
-6,000
| -64% | -$1.64M | 0.03% | 301 |
|
|
2019
Q2 | $4.98M | Sell |
9,333
-667
| -7% | -$356K | 0.11% | 159 |
|
|
2019
Q1 | $5.04M | Buy |
+10,000
| New | +$5.04M | 0.07% | 150 |
|
|
2018
Q3 | – | Sell |
-1,000
| Closed | -$732K | – | 560 |
|
|
2018
Q2 | $732K | Buy |
+1,000
| New | +$732K | 0.01% | 384 |
|